v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (UNAUDITED) - USD ($)
Members
Series A
As Previously Reported
Members
Series A
Adjustments
Members
Series B Units
As Previously Reported
Members
Series B Units
Adjustments
Members
Series C
As Previously Reported
Members
Series C
Adjustments
Common Shares
Adjustments
Common Shares
Additional Paid-In Capital
Accumulated Deficit
As Previously Reported
Accumulated Deficit
Adjustments
Accumulated Deficit
As Previously Reported
Total
Balance as of beginning at Dec. 31, 2023             $ 454 $ 454   $ (159,184,883) $ (454) $ (159,185,337) $ (159,184,883) $ (159,184,883)
Balance as of beginning (in units) at Dec. 31, 2023 245,300 (245,300) 9,906,827 (9,906,827) 1,584,327 (1,584,327) 4,584,273              
STATEMENTS OF MEMBERS' DEFICIT                            
Adjustment to shareholder receivables                 $ (630)         (630)
Preferred A Unit dividend                 630     (545,989)   (545,359)
Net income (loss)                       (18,437,453)   (18,437,453)
Balance as of ending at Mar. 31, 2024               $ 454       (178,168,779)   (178,168,325)
Balance as of ending (in units) at Mar. 31, 2024               4,584,273            
Balance as of beginning at Dec. 31, 2023             $ 454 $ 454   (159,184,883) (454) (159,185,337) (159,184,883) $ (159,184,883)
Balance as of beginning (in units) at Dec. 31, 2023 245,300 (245,300) 9,906,827 (9,906,827) 1,584,327 (1,584,327) 4,584,273              
STATEMENTS OF MEMBERS' DEFICIT                            
Reverse recapitalization transactions, net (in shares)                           18,732,670
Balance as of ending at Dec. 31, 2024             $ 1,418 $ 1,418   $ (184,476,592) $ (1,418) (184,478,010) $ (184,476,592) $ (184,476,592)
Balance as of ending (in units) at Dec. 31, 2024 245,300 (245,300) 9,906,827 (9,906,827) 1,584,327 (1,584,327) 14,184,397 14,184,397            
STATEMENTS OF MEMBERS' DEFICIT                            
Conversion of debt to common shares               $ 225 7,917,711         7,917,936
Conversion of debt to common shares (in shares)               2,248,945            
Issuance of common shares for the settlement of accounts payable               $ 110 2,567,242         2,567,352
Issuance of common shares for the settlement of accounts payable (in shares)               1,101,868            
Settlement of derivative liabilities into common shares               $ 259 5,906,181         5,906,440
Settlement of derivative liabilities into common shares (in shares)               2,593,000            
Issuance of common shares in connection with non-redemption agreements               $ 40 901,049         901,089
Issuance of common shares in connection with non-redemption agreements (in shares)               404,076            
Share-based compensation               $ 23 470,228         470,250
Share-based compensation (in shares)               225,000            
Common shares issued in exchange for cash               $ 30 999,970         $ 1,000,000
Common shares issued in exchange for cash (in shares)               303,951           6,876,840
Reverse recapitalization transactions, net               $ 455 112,464,679         $ 112,465,134
Reverse recapitalization transactions, net (in shares)               4,548,273            
Net income (loss)                       (2,687,437)   (2,687,437)
Balance as of ending at Mar. 31, 2025               $ 2,561 $ 131,227,060     $ (187,165,447)   $ (55,935,827)
Balance as of ending (in units) at Mar. 31, 2025               25,609,510